Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Mason Hawkins, latest 13F

Regeneron Pharmaceuticals

In Mason Hawkins's portfolio · Longleaf Partners

Ticker REGN

Still in the portfolio as of Q3 2026. Every quarter it shows up in a Longleaf Partners 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2026 Reduce 8% 140,165 5.8% $758.27 $106.3M
Q2 2026 Add 17% 152,322 5.0% $623.54 $95.0M
Q1 2026 Reduce 21% 130,662 5.0% $772.64 $101.0M
Q4 2025 Add 15% 165,792 5.7% $771.87 $128.0M
Q3 2025 Reduce 10% 144,607 4.2% $562.27 $81.3M
Q2 2025 Add 40% 160,581 4.3% $525.00 $84.3M
Q1 2025 Buy 114,880 3.9% $634.23 $72.9M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.